⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
Artificial Intelligence (AI) for De Novo Drug Design Global Market Report 2026 | Secure 33.7% CAGR Through 2030 with Schrödinger, XtalPi, Owkin, Insilico Medicine and Recursion
globenewswire.com
BNTX
TRX
Targeted Drug Delivery Market Size, Share, Trends, and Global Forecast, 2026-2036 | $57.5 Billion Opportunity Fueled by ADCs, LNPs, and 16.5% CAGR
globenewswire.com
PFE
GILD
ABBV
JNJ
ALNY
ARWR
IONS
MRNA
BNTX
HALO
ADCT
AZN
REGN
Computer and Peripherals Standard Logic IC Market Analysis and Growth Forecasts, 2026-2031 | Low-Voltage Logic and Asia-Pacific Demand Propel Market to USD 48.72 Billion
globenewswire.com
TXN
ON
ADI
MPWR
LRCX
AMAT
NVDA
INTC
AMD
MU
QCOM
NXPI
INFY
WDC
SWKS
DIOD
MCHP
STM
TER
ASML
KLAC
ENPH
PLUG
FCEL
ALGN
CRSP
MRNA
BNTX
TSM
AVGO
AMZN
GOOGL
MSFT
AAPL
DELL
HPQ
IBM
QTRX
A Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better Targets
globenewswire.com
MRNA
BNTX
MRK
HYFT
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer
globenewswire.com
BNTX
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
globenewswire.com
BNTX
BMY
Metastatic HR+/HER2- Breast Cancer - Market Insights, Epidemiology, Competitive Landscape, and Market Forecast - 2036 | 8% CAGR Fueled by Oral SERDs, ADCs, and Targeted Therapies
globenewswire.com
PFE
LLY
AZN
GILD
MRK
ARVN
OMER
CELC
BNTX
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
globenewswire.com
BNTX
GILD
Nutraceutical Ingredients Market Forecasts Growth from $108.33 Billion (2026) to $161.53 Billion by 2031, Profiling Cargill, ADM, dsm-firmenich, Kerry & 21 Other Key Players
globenewswire.com
ADM
IFF
BG
LIN
MKC
NOV
PG
SCL
SYK
T
TGT
TSN
WMT
XOM
ZTS
BCH
KDP
GIS
CPB
HRL
KHC
SJM
CL
PEP
KO
COST
CVX
BA
CAT
DIS
GE
GS
JNJ
JPM
MCD
MRK
MSFT
PFE
PM
RTX
SBUX
SPG
UNH
UPS
VZ
WFC
AMZN
GOOGL
AAPL
NVDA
TSLA
META
NFLX
CMCSA
INTC
AMD
QCOM
AMGN
GILD
BMY
ABBV
LLY
NVO
AZN
BNTX
MRNA
CRSP
REGN
VRTX
BIIB
ALKS
BMRN
EXAS
ILMN
MELI
PYPL
COIN
MARA
ETSY
JD
BABA
NTES
PDD
BIDU
EDU
TAL
BEKE
NIO
LI
XPEV
RIVN
LCID
PLTR
SNOW
DDOG
CRWD
PANW
ZS
FTNT
NOW
CRM
ADSK
CSCO
IBM
ORCL
SAP
ACN
MU
WDC
EXPE
BKNG
MAR
HLT
RH
KOS
INGR
CARG
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
globenewswire.com
BNTX